Thomas Ebeling - Jun 10, 2024 Form 4 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Role
Director
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Stock symbol
CGEM
Transactions as of
Jun 10, 2024
Transactions value $
$239,850
Form type
4
Date filed
6/11/2024, 06:00 PM
Previous filing
May 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Options Exercise $240K +18.5K +10.97% $13.00 187K Jun 10, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGEM Stock Option (Right to Buy) Options Exercise $0 -18.5K -100% $0.00* 0 Jun 10, 2024 Common Stock 18.5K $13.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.